Vimarsana
Biggest News Aggregation in the World

Page 3 - Randall Stanicky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Randall Stanicky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Randall Stanicky Today - Breaking & Trending Today

Endo International plc (ENDP) Q4 2020 Earnings Call Transcript - Vimarsana News

Endo International plc (ENDP) Q4 2020 Earnings Call Transcript

Operator Good morning, ladies and gentlemen, and welcome to the Fourth Quarter 2020 Endo International plc Earnings Conference Call.[Operator Instructions] I would now like to turn the conference over to your host, Ms. Laure Park, Vice President, Investor Relations and Corp Affairs. Please go ahead. Laure Park -- Senior Vice President, Investor Relations and Corporate Affairs Good morning and thank you for joining us to discuss our fourth quarter and full year 2020 financial results. Joining me on today's call are Blaise Coleman, President and CEO of Endo; Mark Bradley, Executive Vice Presid...

Source: fool.com
Stock picks to buy, best 2021 small-cap growth picks from RBC - Vimarsana News

Stock picks to buy, best 2021 small-cap growth picks from RBC

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. RBC just updated its list of the most highly recommended small-cap stocks for the first quarter. Small-company stocks have been on an enormous rally that included their best month ever in November. Some experts say they still have a long way to go to catch up to the relative prices of large caps. The smallest companies on Wall Street have had a remarkable run over the past few months, and they still have a long way to go to catch up with the stock market's g...

Why Pfizer's Stock Has Reached Its Limit, According to One Analyst - Vimarsana News

Why Pfizer's Stock Has Reached Its Limit, According to One Analyst

Order Reprints Text size Pfizer's Covid-19 vaccine arrived at Rady Children's Hospital in San Diego on Tuesday. ARIANA DREHSLER/AFP/Getty Images As Americans roll up their sleeves this week for the Covid-19 vaccine developed by BioNTech, RBC Capital analyst Randall Stanicky says Pfizer’s accomplishment “is nothing short of remarkable.” In a Wednesday note, the analyst remarks that Pfizer got the vaccine to market in record time, while refusing federal money given to rival developers, including Moderna. But with Pfizer’s stock (ticker: PFE) reaching a Tu...

Wednesday's analyst upgrades and downgrades - The Globe and Mail - Vimarsana News

Wednesday's analyst upgrades and downgrades - The Globe and Mail

The Globe and Mail Bookmark Please log in to listen to this story. Also available in French and Mandarin. Log In Create Free Account Getting audio file ... This translation has been automatically generated and has not been verified for accuracy. Full Disclaimer Inside the Market’s roundup of some of today’s key analyst actions Though he thinks its US$1.68-billion acquisition of TC Pipelines LP (TCP-N) “does not move the needle in terms of upside,” Industrial Alliance Securities analyst Elias Foscolos raised his rating for TC Energy Corp. (TRP-T) to “strong buy” from “bu...

It's official: Pfizer, BioNTech COVID-19 shot grabs emergency FDA nod, clearing way for first U.S. vaccinations - Vimarsana News

It's official: Pfizer, BioNTech COVID-19 shot grabs emergency FDA nod, clearing way for first U.S. vaccinations

Dec 11, 2020 9:50pm Next up? The first doses should be on their way to providers “within hours,” as promised by Pfizer CEO Albert Bourla. (Pfizer) That was fast. Just over 24 hours after an FDA advisory panel recommended emergency use of Pfizer and BioNTech’s COVID-19 vaccine, the agency followed through, authorizing the first coronavirus pandemic shot for emergency use in the U.S. The FDA had planned to authorize the vaccine on Saturday, but moved the timeline up after pressure from the White House. With the Emergency Use Authorization in hand, Pfizer can now speed millions o...